UNSPSC 51284015: Pipacycline

This classification denotes a tetracycline antibiotic with the molecular formula C29H38N4O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, PQ3P6082I5 chemically known as 4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-penta-hydroxy-n-((4-(2-hydroxyethyl)-1-piperazinyl)methyl)-6-methyl-1,11-dioxo-2-naphthacenecarboxamide but generally known as pipacycline, which bears US NIH Compound Identifier 5357020.

UNSPSC 51284015 Pipacycline, a Commodity code, shows a mismatch between its nominal scope and the work actually being solicited under it at the state and local level. Recent opportunities posted against this code involve naloxone (opioid antagonist), safe drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, and medical and first aid supplies — none of which are pipacycline, an antibiotic in the tetracycline family. The code appears to be a misclassification or data-entry error in state and local procurement systems rather than an active procurement category for the named product. Issuing bodies range from county health agencies (Seminole County, Florida) to state health and human services commissions (Texas HHS, Minnesota Department of Administration), municipal fire departments (City of Tampa), and cooperative purchasing alliances (MMCAP). The actual purchasing mix reflects emergency medical supplies, harm-reduction pharmaceuticals, and generic pharmaceutical distribution — categories substantially different from pipacycline's therapeutic and clinical positioning.

Geographic activity appears concentrated in Florida, Texas, and Minnesota based on the recent postings, with MMCAP's multistate cooperative purchasing framework extending reach across Oregon and other participating jurisdictions. Representative recent opportunities include Seminole County's IFB 60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023; the City of Tampa's IFB 26P00145 for medical and first aid supplies estimated at $700,000.00 with a March 13, 2026 response date and a 5 percent SLBE bid discount; Texas HHS's RFI HHS0017013 (posted April 3, 2026) for direct-to-manufacturer prescription program capabilities; and MMCAP's RFP S1070000015802 for generic multi-source pharmaceuticals with a March 26, 2026 response deadline. This code shows minimal relevant recent activity aligned with pipacycline procurement and warrants review for proper recategorization in state and local procurement databases.